Bionano Genomics, Inc. Deferred Revenue
Bionano Genomics, Inc. (BNGO) had Deferred Revenue of $871.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2023-03-09
- 2022-12-31: Deferred Revenue, Current $871.00K.
- 2021-12-31: Deferred Revenue, Current $684.00K.
- 2020-12-31: Deferred Revenue, Current $416.00K; Deferred Revenue, Current as first filed $415.50K.
- 2019-12-31: Deferred Revenue, Current $357.49K.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2022-12-31 | $871.00K 10-K · filed 2023-03-09 | |
| 2021-12-31 | $684.00K 10-K · filed 2023-03-09 | |
| 2020-12-31 | $416.00K 10-K · filed 2022-03-01 | $415.50K 10-K · filed 2021-03-23 |
| 2019-12-31 | $357.49K 10-K · filed 2021-03-23 | |
| 2019-03-31 | $213.90K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $271.00K 10-K · filed 2020-03-10 | |
| 2018-09-30 | $335.60K 10-Q · filed 2018-11-07 | |
| 2017-12-31 | $211.70K 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |